Home
Conditions
Meningococcal Infections

Clinical trial condition

Meningococcal Infections

Explore clinical trials studying Meningococcal Infections. Study availability and eligibility vary by location and protocol.

52 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Meningococcal Infections trial results

Completed

Safety and Immunogenicity Evaluation After One or Two Doses of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants and Toddlers

NCT00667602

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations: Site 22 Bad Kreuznach, Germany

Site 38 Bad Lobenstein, Germany

Site 24 Balve, Germany

Site 3 Berlin, Germany

View all 28 locations

View Trial Details

Completed

Study Evaluating the Tolerance of Conjugate Meningococcal C Vaccine in Infants

NCT00314041

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations: Not specified

View Trial Details

Completed

Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®

NCT00355121

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +31 more
Locations: Little Rock, Arkansas, United States

Boulder, Colorado, United States

Atlanta, Georgia, United States

Layton, UT 84041, Georgia, United States

View all 26 locations

View Trial Details

Completed

Safety And Blood Collection Study Of Meningococcal B Rlp2086 Vaccine In Adults

NCT00780806

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations: Pfizer Investigational Site Herston, Australia

Pfizer Investigational Site North Adelaide, Australia

Pfizer Investigational Site Subiaco, Australia

View Trial Details

Completed

Safety, Immunogenicity and Reactogenicity Trial of Mencevax ACW135 Vaccine

NCT00994695

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations: Butajira Hospital Butajīra, Southern Nationality, Ethiopia

View Trial Details

Completed

Study Evaluating the Safety, Immunogenicity and Tolerability of Meningococcal Group B Vaccine in Healthy Adults

NCT00297687

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations: Herson, Queensland, Australia

North Adealaide, South Australia, Australia

Perth, Western Australia, Australia

View Trial Details

Active, Not Recruiting

Safety, Tolerability, and Immunogenicity of MenABCWY Administered on Different Dosing Schedules in Healthy Adolescents

NCT05087056

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations: GSK Investigational Site Tucson, Arizona, United States

GSK Investigational Site Ventura, California, United States

GSK Investigational Site Macon, Georgia, United States

GSK Investigational Site Valparaiso, Indiana, United States

View Trial Details

Active, Not Recruiting

Phase IV Clinical Study of Immunogenicity of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector)

NCT05935176

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations: Wuzhi County Center for Disease Control and Prevention Jiaozuo, Henan, China

View Trial Details

Active, Not Recruiting

Clinical Study of the Safety of Menhycia® in 3-Month-Old Infants

NCT06389513

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations: Nanjing Luhe District Center for Disease Control and Prevention Center for Disease Control and Prevention Nanjing, China

View Trial Details

Active, Not Recruiting

A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in 7 to 17 Year Olds

NCT06700148

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations: Dengfeng Center for Disease Control and Prevention Dengfeng, China

Kaifeng Center for Disease Control and Prevention Kaifeng, China

View Trial Details

Meningococcal Infections

Meningococcal Infections trial results

Related conditions